Michael Scolaro

Michael Scolaro

Sep 16, 2017

Group 6 Copy 175
3
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Developing a new tissue preservation method inspired by Tardigrades

There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

Does Antidepressant Use by Breastfeeding Mothers Lead to Autism?

The aim of the current project is to investigate the consequences of developmental exposure to antidepressants...

Backer Badge Funded